LAP3 and dermatomyositis: It is speculated that the widely acknowledged crucial pathway in DM triggers the increase in IFI27, CMPK and LAP3 expression, potentially exacerbating mitochondrial dysfunction and augmenting the production of ROS and inflammation in DM.